We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final EMEA Guideline on Excipients Excludes Products in Development
Final EMEA Guideline on Excipients Excludes Products in Development
September 4, 2007
The European Medicines Agency’s (EMEA) final guideline on data submission requirements for excipients in marketing authorization applications does not apply to drug products currently in the clinical research stages of development.